Vr Adviser, LLC 4 D Molecular Therapeutics, Inc. Transaction History
Vr Adviser, LLC
- $606 Million
- Q4 2024
A detailed history of Vr Adviser, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 2,952,371 shares of FDMT stock, worth $14.5 Million. This represents 2.71% of its overall portfolio holdings.
Number of Shares
2,952,371
Previous 4,400,000
32.9%
Holding current value
$14.5 Million
Previous $47.6 Million
65.43%
% of portfolio
2.71%
Previous 4.93%
Shares
4 transactions
Others Institutions Holding FDMT
# of Institutions
147Shares Held
46.7MCall Options Held
121KPut Options Held
33.2K-
Black Rock Inc. New York, NY4.9MShares$24 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$22.4 Million0.41% of portfolio
-
Goldman Sachs Group Inc New York, NY4.27MShares$20.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$14 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.67MShares$13.1 Million0.56% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $159M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...